Literature DB >> 9393900

Mortality and fatal pulmonary embolism after primary total hip replacement. Results from a regional hip register.

D Fender1, W M Harper, J R Thompson, P J Gregg.   

Abstract

We calculated the rates for perioperative mortality and fatal pulmonary embolism (PE) after primary total hip replacement in a single UK health region, using a regional arthroplasty register and the tracing service of the Office of National Statistics. During 1990, there were 2111 consecutive primary replacements in 2090 separate procedures. Within 42 days of operation a total of 19 patients had died (0.91%, 95% CI 0.55 to 1.42). Postmortem examination showed that four deaths (0.19%, 95% CI 0.05 to 0.49) were definitely due to PE. The overall perioperative mortality and fatal PE rates are low and in our study did not appear to be altered by the use of chemical thromboprophylaxis (perioperative mortality rate: one-tailed Fisher's exact test, p = 0.39; fatal PE rate: one-tailed Fisher's exact test, p = 0.56). The routine use of chemical thromboprophylaxis for primary THR is still controversial. The issue should be addressed by an appropriate randomised, prospective study using overall mortality and fatal PE rate as the main outcome measures, but the feasibility of such a study is questioned.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9393900     DOI: 10.1302/0301-620x.79b6.7677

Source DB:  PubMed          Journal:  J Bone Joint Surg Br        ISSN: 0301-620X


  18 in total

Review 1.  The true treatment benefit is unpredictable in clinical trials using surrogate outcome measured with diagnostic tests.

Authors:  Behrouz Kassaï; Nirav R Shah; Alain Leizorovicza; Michel Cucherat; Francois Gueyffier; Jean-Pierre Boissel
Journal:  J Clin Epidemiol       Date:  2005-10       Impact factor: 6.437

Review 2.  Aspirin for lower limb arthroplasty thromboprophylaxis: review of international guidelines.

Authors:  C L Donohoe; M K Sayana; R Thakral; D M Niall
Journal:  Ir J Med Sci       Date:  2010-12-14       Impact factor: 1.568

3.  Primary total hip replacement: variations in patient management in Oxford & Anglia, Trent, Yorkshire & Northern 'regions'.

Authors:  R W Morris; R Fitzpatrick; S Hajat; B C Reeves; D W Murray; D Hannen; M Rigge; O Williams; P J Gregg
Journal:  Ann R Coll Surg Engl       Date:  2001-05       Impact factor: 1.891

4.  Are national guidelines for total hip replacement in the UK reflected in practice?

Authors:  A Abraham; L Hajipour; A R Innes; H Phillips; A W McCaskie
Journal:  Ann R Coll Surg Engl       Date:  2006-03       Impact factor: 1.891

5.  Self-reported complication rates following primary total hip arthroplasty in Ireland: fact or fiction.

Authors:  P Curtin; J Harty; E Sheehan; P Nicholson; J McElwain
Journal:  Ir J Med Sci       Date:  2010-10-10       Impact factor: 1.568

6.  [Prevention of thromboembolism in trauma surgery by dose adjustment of low molecular weight heparin depending on levels of TAT and D-dimer].

Authors:  A Mayer; M Hansen; D Peetz; G Hafner; N Vogel; W Prellwitz; P M Rommens
Journal:  Unfallchirurg       Date:  2003-12       Impact factor: 1.000

7.  Risk Factor Analysis for 30-Day Mortality After Primary THA in a Single Institution.

Authors:  Fernando Comba; Ignacio Alonso Hidalgo; Martín Buttaro; Francisco Piccaluga
Journal:  HSS J       Date:  2012-06-30

8.  Aspirin: an alternative for pulmonary embolism prophylaxis after arthroplasty?

Authors:  Ibrahim J Raphael; Eric H Tischler; Ronald Huang; Richard H Rothman; William J Hozack; Javad Parvizi
Journal:  Clin Orthop Relat Res       Date:  2014-02       Impact factor: 4.176

9.  Symptomatic pulmonary embolus after joint arthroplasty: stratification of risk factors.

Authors:  Javad Parvizi; Ronald Huang; Ibrahim J Raphael; William V Arnold; Richard H Rothman
Journal:  Clin Orthop Relat Res       Date:  2013-11-22       Impact factor: 4.176

10.  Can a new design of pneumatic compression device reduce variations in delivered therapy for the mechanical prophylaxis of thromboembolic disease after total hip arthroplasty?

Authors:  Bassam A Masri; David J Dunlop; James A McEwen; Donald S Garbuz; Clive P Duncan
Journal:  Can J Surg       Date:  2004-08       Impact factor: 2.089

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.